Literature DB >> 1969740

Denaturation-renaturation of the fibrin-stabilizing factor XIII a-chain isolated from human placenta. Properties of the native and reconstituted protein.

U Rinas1, B Risse, R Jaenicke, K J Abel, G Zettlmeissl.   

Abstract

The denaturation-renaturation transition between the native and unfolded states of the dimeric blood coagulation factor XIIIa has been examined by far-UV circular dichroism, fluorescence spectroscopy, activity measurements, sedimentation equilibrium analysis, and size exclusion high performance liquid chromatography. Guanidine hydrochloride and urea-dependent denaturation in the absence and in the presence of 5mM dithioerythritol or glutathione (5mM GSH) exhibit biphasic transitions. The first stage represents a sharp transition characterized by a change in secondary structure without subunit dissociation. This step is accompanied by the irreversible loss of biological activity. The second transition reflects the dissociation and complete unfolding of the protein to a random coil. After loss of biological activity no reactivation can be accomplished under any of the following conditions: (i) denaturation and renaturation under reducing or non-reducing conditions, (ii) variation of the protein concentration and temperature, (iii) addition of specific ligands (Ca2+, substrate), (iv) presence of stabilizing and/or destabilizing agents. Attempts to renature the protein under standard conditions (0.1 M Tris/HCl pH 7.5-9.0, 5mM DTE, 5mM EDTA) lead to refolding intermediates which exhibit a strong tendency to aggregate. A soluble product of reconstitution can be obtained by refolding at low protein concentration, low temperature, and in the presence of small amounts of destabilizing agents such as arginine or urea in the renaturation buffer at pH 7.5 to 9. The spectroscopic and hydrodynamic characterization of the partially reconstituted (non-native inactive) protein shows that partially reconstituted factor XIIIa exhibits the fluorescence properties and the dimeric structure of the native protein.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969740     DOI: 10.1515/bchm3.1990.371.1.49

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  5 in total

1.  Rational design of solution additives for the prevention of protein aggregation.

Authors:  Brian M Baynes; Bernhardt L Trout
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

2.  Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.

Authors:  Anna D Protopopova; Andrea Ramirez; Dmitry V Klinov; Rustem I Litvinov; John W Weisel
Journal:  J Thromb Haemost       Date:  2019-03-14       Impact factor: 5.824

3.  Expression of the human blood coagulation protein factor XIIIa in Saccharomyces cerevisiae: dependence of the expression levels from host-vector systems and medium conditions.

Authors:  M Bröker; O Bäuml; A Göttig; J Ochs; M Bodenbenner; E Amann
Journal:  Appl Microbiol Biotechnol       Date:  1991-03       Impact factor: 4.813

4.  Dissociation, unfolding and refolding trials of pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase.

Authors:  P Dominici; P S Moore; C Borri Voltattorni
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

5.  Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key.

Authors:  Utpal Das; Gururao Hariprasad; Abdul S Ethayathulla; Pallavi Manral; Taposh K Das; Santosh Pasha; Anita Mann; Munia Ganguli; Amit K Verma; Rajiv Bhat; Sanjeev Kumar Chandrayan; Shubbir Ahmed; Sujata Sharma; Punit Kaur; Tej P Singh; Alagiri Srinivasan
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.